Prediction of adverse drug reactions due to genetic predisposition using deep neural networks
Molecular Informatics · 2024
DOI: 10.1002/minf.202400021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Informatics, 2024. Verfasst von Bryan Dafniet und 1 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1133, CNRS UMR 8251, Université Paris Cité, 35 rue Hélène Brion, Paris, 75013, France. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Polymorphism, Single Nucleotide, Genetic Predisposition to Disease, Deep Learning. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the European Union's Horizon 2020.
Abstract (Originalsprache)
Drug development is a long and costly process, often limited by the toxicity and adverse drug reactions (ADRs) caused by drug candidates. Even on the market, some drugs can cause strong ADRs that can vary depending on an individual polymorphism. The development of Genome‐wide association studies (GWAS) allowed the discovery of genetic variants of interest that may cause these effects. In this study, the objective was to investigate a deep learning approach to predict genetic variations potentially related to ADRs. We used single nucleotide polymorphisms (SNPs) information from dbSNP to create a network based on ADR‐drug‐target‐mutations and extracted matrixes of interaction to build deep Neural Networks (DNN) models. Considering only information about mutations known to impact drug efficacy and drug safety from PharmGKB and drug adverse reactions based on the MedDRA System Organ Classes (SOCs), these DNN models reached a balanced accuracy of 0.61 in average. Including molecular fingerprints representing structural features of the drugs did not improve the performance of the models. To our knowledge, this is the first model that exploits DNN to predict ADR‐drug‐target‐mutations. Although some improvements are suggested, these models can be of interest to analyze multiple compounds over all of the genes and polymorphisms information accessible and thus pave the way in precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- INSERM U1133, CNRS UMR 8251, Université Paris Cité, 35 rue Hélène Brion, Paris, 75013, France.
Förderung
- the European Union's Horizon 2020
Zitieren
APA
Dafniet, B., & Taboureau, O. (2024). Prediction of adverse drug reactions due to genetic predisposition using deep neural networks. Molecular Informatics. https://doi.org/10.1002/minf.202400021
Vancouver
Dafniet B, Taboureau O. Prediction of adverse drug reactions due to genetic predisposition using deep neural networks. Molecular Informatics. 2024. doi:10.1002/minf.202400021
BibTeX
@article{Dafniet2024,
author = {Dafniet, Bryan and Taboureau, Olivier},
title = {Prediction of adverse drug reactions due to genetic predisposition using deep neural networks},
journal = {Molecular Informatics},
year = {2024},
doi = {10.1002/minf.202400021}
}
EUVIMED